Envestnet Asset Management Inc. Increases Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Envestnet Asset Management Inc. increased its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 1.0% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 211,794 shares of the company's stock after acquiring an additional 2,107 shares during the quarter. Envestnet Asset Management Inc. owned about 0.09% of HCA Healthcare worth $73,185,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Hexagon Capital Partners LLC boosted its holdings in shares of HCA Healthcare by 15.6% in the first quarter. Hexagon Capital Partners LLC now owns 703 shares of the company's stock worth $243,000 after acquiring an additional 95 shares during the period. Penserra Capital Management LLC grew its stake in HCA Healthcare by 147.6% during the first quarter. Penserra Capital Management LLC now owns 3,320 shares of the company's stock valued at $1,146,000 after acquiring an additional 1,979 shares in the last quarter. Maj Invest Holding A S bought a new position in HCA Healthcare in the 1st quarter valued at $109,823,000. Concurrent Investment Advisors LLC raised its position in shares of HCA Healthcare by 5.2% in the first quarter. Concurrent Investment Advisors LLC now owns 2,142 shares of the company's stock worth $740,000 after buying an additional 106 shares in the last quarter. Finally, Seascape Capital Management grew its position in HCA Healthcare by 0.9% during the first quarter. Seascape Capital Management now owns 13,575 shares of the company's stock worth $4,691,000 after buying an additional 117 shares in the last quarter. Institutional investors own 62.73% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on HCA shares. Morgan Stanley set a $410.00 price target on shares of HCA Healthcare and gave the stock an "equal weight" rating in a research note on Monday, June 9th. Robert W. Baird reiterated a "neutral" rating and issued a $336.00 price objective (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Barclays set a $416.00 price target on shares of HCA Healthcare and gave the company an "overweight" rating in a research report on Monday, June 2nd. Royal Bank Of Canada restated an "outperform" rating and set a $404.00 price target (up from $376.00) on shares of HCA Healthcare in a research report on Monday, June 23rd. Finally, Guggenheim began coverage on HCA Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating on the stock. Seven equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $395.71.

Insiders Place Their Bets

In related news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the transaction, the chief operating officer directly owned 12,646 shares in the company, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.30% of the company's stock.

HCA Healthcare Stock Down 0.7%

NYSE HCA traded down $2.56 during trading hours on Friday, reaching $375.76. 877,097 shares of the company's stock traded hands, compared to its average volume of 1,341,639. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. The firm has a market cap of $90.40 billion, a PE ratio of 16.29, a PEG ratio of 1.31 and a beta of 1.47. The firm has a 50-day simple moving average of $374.58 and a 200 day simple moving average of $341.23.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.75 by $0.70. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The firm had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. During the same quarter in the prior year, the firm posted $5.36 earnings per share. The business's revenue was up 5.7% on a year-over-year basis. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Monday, June 16th were given a dividend of $0.72 per share. The ex-dividend date was Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.77%. HCA Healthcare's dividend payout ratio (DPR) is 12.81%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.